Image

Risk Prediction of Disease Progression in Early-Onset Coronary Atherosclerosis

Risk Prediction of Disease Progression in Early-Onset Coronary Atherosclerosis

Recruiting
18-45 years
All
Phase N/A

Powered by AI

Overview

This study is part of a nationwide research project in China that aims to better understand how coronary artery disease develops and progresses in young adults. The study will enroll approximately 10,000 participants aged 45 years or younger who undergo coronary CT scans at multiple hospitals across China.

Information collected at enrollment includes basic health information, cardiovascular risk factors, blood test results, medication use, lifestyle habits, and, for some participants, genetic data. Participants will undergo follow-up coronary CT scans after several years to evaluate changes in coronary artery plaque and disease progression.

By analyzing these clinical and imaging data, the study aims to identify factors associated with disease progression and to develop prediction models that may help estimate an individual's future risk of coronary plaque progression and cardiovascular events. The results of this study may contribute to improved risk assessment and early prevention strategies for coronary artery disease in young populations.

Eligibility

Inclusion Criteria:

  1. Age between 18 and 45 years at the time of enrollment.
  2. Presence of symptoms suggestive of coronary artery disease and completion of coronary computed tomography (CT) examination.
  3. Ability and willingness to provide written informed consent and to participate in follow-up assessments.

Exclusion Criteria:

  1. Inability or unwillingness to complete follow-up assessments.
  2. Inability to provide written informed consent.
  3. History of coronary revascularization, including percutaneous coronary intervention or coronary artery bypass grafting.
  4. Poor-quality coronary computed tomography images that are inadequate for reliable plaque assessment.
  5. Presence of severe systemic disease with limited life expectancy that may interfere with study follow-up.
  6. Pregnant or breastfeeding women.
  7. Participation in another clinical study that may interfere with the outcomes of this study.

Study details
    Coronary Disease
    Young Adult

NCT07316452

Fu Wai Hospital, Beijing, China

31 January 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.